.
BCTX financial statements
* Numbers in thousands
Year |
2021 | TTM |
|---|---|---|
Capitalization * |
30 688 | 38 145 |
EV * |
-26 555 | -26 555 |
Stock price $ |
6.79 | 8.44 |
Number of shares * |
4 520 | 4 520 |
EPS |
-0,09 | -0,09 |
Revenue * |
0 | 0 |
Net income * |
-428 | -428 |
Operating profit * |
-6 970 | -6 970 |
Total liabilities * |
782 | 782 |
Net debt * |
-57 243 | -57 243 |
Total assets * |
58 044 | 58 044 |
Equity * |
57 262 | 57 262 |
Cash and investments * |
57 269 | 57 269 |
Over the past 10 years, the maximum capitalization of BriaCell Therapeutics Corp. is 30 688, the minimum is 30 688. Maximum net income 0, Minimum net income -428. The maximum price of BCTX shares is 6.79, the minimum price is 6.79.
.
BCTX valuation
Year |
2021 | TTM |
|---|---|---|
P/E |
-71,64 | -89,05 |
P/B |
0,54 | 0,67 |
P/S |
0,00 | 0,00 |
E/P |
-1% | -1% |
P/FCF |
-3,96 | -4,92 |
.
BCTX profitability
Year |
2021 | TTM |
|---|---|---|
ROE |
-1% | |
ROA |
-1% | |
ROIC |
-12% |